Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Velsipity™ (etrasimod) – New drug approval
October 13, 2023 - Pfizer announced the FDA approval of Velsipity (etrasimod), for the treatment of moderately to severely active ulcerative colitis (UC) in adults.
